Vorozole

Vorozole is a nonsteroidal inhibitor of aromatase that is used in the treatment of breast cancer. It is classified as an antiestrogen and is similar in structure and function to anastrozole and letrozole.

Mechanism of Action[edit | edit source]

Vorozole works by inhibiting the enzyme aromatase, which is responsible for the conversion of androgens (male hormones) into estrogens (female hormones). By blocking this conversion, vorozole effectively reduces the levels of estrogen in the body, which can slow or stop the growth of certain types of breast cancer cells that require estrogen to grow.

Uses[edit | edit source]

Vorozole is primarily used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. It may also be used in cases where other treatments have failed or are not suitable.

Side Effects[edit | edit source]

Common side effects of vorozole include hot flashes, nausea, vomiting, and fatigue. Less common but more serious side effects can include bone loss and fractures, hypercholesterolemia, and cardiovascular disease.

Contraindications[edit | edit source]

Vorozole is contraindicated in premenopausal women and in patients with known hypersensitivity to vorozole or any of its components.

See Also[edit | edit source]

Vorozole Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.